Towards an optimal model for gastric cancer peritoneal metastasis: current challenges and future directions

Summary: Peritoneal metastasis is a challenging aspect of clinical practice for gastric cancer. Animal models are crucial in understanding molecular mechanisms, assessing drug efficacy, and conducting clinical intervention studies, including those related to gastric cancer peritoneal metastasis. Unl...

Full description

Bibliographic Details
Main Authors: Zehui Li, Jin Wang, Zhenning Wang, Yan Xu
Format: Article
Language:English
Published: Elsevier 2023-06-01
Series:EBioMedicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396423001664
_version_ 1797828131927621632
author Zehui Li
Jin Wang
Zhenning Wang
Yan Xu
author_facet Zehui Li
Jin Wang
Zhenning Wang
Yan Xu
author_sort Zehui Li
collection DOAJ
description Summary: Peritoneal metastasis is a challenging aspect of clinical practice for gastric cancer. Animal models are crucial in understanding molecular mechanisms, assessing drug efficacy, and conducting clinical intervention studies, including those related to gastric cancer peritoneal metastasis. Unlike other xenograft models, peritoneal metastasis models should not only present tumor growth at the transplant site, but also recapitulate tumor cell metastasis in the abdominal cavity. Developing a reliable model of gastric cancer peritoneal metastasis involves several technical aspects, such as the selection of model animals, source of xenograft tumors, technology of transplantation, and dynamic monitoring of the tumor progression. To date, challenges remain in developing a reliable model that can completely recapitulate peritoneal metastasis. Thus, this review aims to summarize the techniques and strategies used to establish animal models of gastric cancer peritoneal metastasis, providing a reference for future model establishment.
first_indexed 2024-04-09T12:59:48Z
format Article
id doaj.art-9b9d6f7fa83f4f0bbea3f4e707adeb2e
institution Directory Open Access Journal
issn 2352-3964
language English
last_indexed 2024-04-09T12:59:48Z
publishDate 2023-06-01
publisher Elsevier
record_format Article
series EBioMedicine
spelling doaj.art-9b9d6f7fa83f4f0bbea3f4e707adeb2e2023-05-13T04:25:16ZengElsevierEBioMedicine2352-39642023-06-0192104601Towards an optimal model for gastric cancer peritoneal metastasis: current challenges and future directionsZehui Li0Jin Wang1Zhenning Wang2Yan Xu3Department of Surgical Oncology and General Surgery, First Hospital of China Medical University, Shenyang, 110001, PR ChinaDepartment of E.N.T., Shengjing Hospital of China Medical University, Shenyang, 110003, PR ChinaDepartment of Surgical Oncology and General Surgery, First Hospital of China Medical University, Shenyang, 110001, PR China; Corresponding author.Department of Surgical Oncology and General Surgery, First Hospital of China Medical University, Shenyang, 110001, PR China; Corresponding author.Summary: Peritoneal metastasis is a challenging aspect of clinical practice for gastric cancer. Animal models are crucial in understanding molecular mechanisms, assessing drug efficacy, and conducting clinical intervention studies, including those related to gastric cancer peritoneal metastasis. Unlike other xenograft models, peritoneal metastasis models should not only present tumor growth at the transplant site, but also recapitulate tumor cell metastasis in the abdominal cavity. Developing a reliable model of gastric cancer peritoneal metastasis involves several technical aspects, such as the selection of model animals, source of xenograft tumors, technology of transplantation, and dynamic monitoring of the tumor progression. To date, challenges remain in developing a reliable model that can completely recapitulate peritoneal metastasis. Thus, this review aims to summarize the techniques and strategies used to establish animal models of gastric cancer peritoneal metastasis, providing a reference for future model establishment.http://www.sciencedirect.com/science/article/pii/S2352396423001664Gastric cancerPeritoneal metastasisAnimal modelImmunodeficient mousePatient-derived xenograft (PDX)Cell line-derived xenograft (CDX)
spellingShingle Zehui Li
Jin Wang
Zhenning Wang
Yan Xu
Towards an optimal model for gastric cancer peritoneal metastasis: current challenges and future directions
EBioMedicine
Gastric cancer
Peritoneal metastasis
Animal model
Immunodeficient mouse
Patient-derived xenograft (PDX)
Cell line-derived xenograft (CDX)
title Towards an optimal model for gastric cancer peritoneal metastasis: current challenges and future directions
title_full Towards an optimal model for gastric cancer peritoneal metastasis: current challenges and future directions
title_fullStr Towards an optimal model for gastric cancer peritoneal metastasis: current challenges and future directions
title_full_unstemmed Towards an optimal model for gastric cancer peritoneal metastasis: current challenges and future directions
title_short Towards an optimal model for gastric cancer peritoneal metastasis: current challenges and future directions
title_sort towards an optimal model for gastric cancer peritoneal metastasis current challenges and future directions
topic Gastric cancer
Peritoneal metastasis
Animal model
Immunodeficient mouse
Patient-derived xenograft (PDX)
Cell line-derived xenograft (CDX)
url http://www.sciencedirect.com/science/article/pii/S2352396423001664
work_keys_str_mv AT zehuili towardsanoptimalmodelforgastriccancerperitonealmetastasiscurrentchallengesandfuturedirections
AT jinwang towardsanoptimalmodelforgastriccancerperitonealmetastasiscurrentchallengesandfuturedirections
AT zhenningwang towardsanoptimalmodelforgastriccancerperitonealmetastasiscurrentchallengesandfuturedirections
AT yanxu towardsanoptimalmodelforgastriccancerperitonealmetastasiscurrentchallengesandfuturedirections